𝔖 Bobbio Scriptorium

✦ LIBER ✦

A randomized, double-blind, vehicle-controlled, multi-center study to evaluate the safety and efficacy of topically applied AN0128 cream, 1% for the treatment of mild to moderate atopic dermatitis

Book ID: 116582429
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 71 KB
Volume: 56
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2006.10.348

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a randomized, double-blind, v

Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis

✍ Erin M. Warshaw; Ross Jon Wohlhuter; An Liu; Sarah A. Zeller; Rachel A. Wenner; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 176 KB

A double-blind, randomized, vehicle-cont

A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIRTM) in the management of atopic dermatitis in paediatric patients

✍ Annalisa Patrizi; Bruno Capitanio; Iria Neri; Federica Giacomini; Jo L. Sinagra; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

A randomized, double-blind, vehicle-cont

A randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of topical diclofenac 3% gel for the treatment of rosacea

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A multicenter, randomized, vehicle-contr

A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP nonsteroidal cream in the management of mild to moderate atopic dermatitis in infants and children

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Forty-two–week safety study of topical n

Forty-two–week safety study of topical nanoemulsion (NB-002) for the treatment of mild to moderate distal subungual onychomycosis: A randomized, double-blind, vehicle-controlled trial

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB

An investigator-blind, randomized, 4-wee

An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face

✍ Boni Elewski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 385 KB